tiprankstipranks
Gyre Therapeutics (GYRE)
NASDAQ:GYRE
US Market

Gyre Therapeutics (GYRE) Cash flow

827 Followers

Gyre Therapeutics Cash Flow

GYRE's free cash flow for Q4 2025 was $-5.77M. For the 2025 fiscal year, GYRE's free cash flow was decreased by $6.59M and operating cash flow was $-5.63M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Mar 22
Operating Cash Flow
$ 1.01M$ -3.64M$ 25.89M$ 10.68M$ -83.75M
Investing Cash Flow
$ -474.00K$ -19.88M$ -19.76M$ -13.81M$ 48.19M
Financing Cash Flow
$ 24.38M$ 2.10M$ 2.50M$ 0.00$ 49.55M
End Cash Position
$ 37.07M$ 11.81M$ 33.51M$ 25.18M$ 44.35M
Free Cash Flow
$ -180.00K$ -6.77M$ 17.31M$ 5.68M$ -84.59M
Currency in USD

Gyre Therapeutics Cash Flow